# 99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization

> **NCT03546478** · EARLY_PHASE1 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 32 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** 99mTc-ABH2

## Key facts

- **NCT ID:** NCT03546478
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-24
- **Primary completion:** 2017-05-24
- **Final completion:** 2018-05-18
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03546478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03546478, "99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03546478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*